cropper
update
Strategy Advantedge
update
  • Home
  • Categories
    • Smart Living
    • AI Integration
    • Tech Trends
    • Home Automation
    • Eco Solutions
    • DIY Projects
    • Expert Insights
May 11.2026
2 Minutes Read

Daisy Ramps Up Smart Home Services with New Franchise Locations in Charlotte, Las Vegas, and Sugar Land

Daisy franchise expansion logo with stylized elements

Revving Up Franchise Growth in Tech Services

In a remarkable acceleration of growth, Daisy is set to enhance its franchise footprint with new locations in Charlotte, North Carolina, Las Vegas, Nevada, and Sugar Land, Texas. This expansion marks a significant milestone for the smart home technology company, bringing its total franchise units to six in 2026 and a cumulative 26 agreements signed since launching its franchise program in early 2024.

Strong Community Connections Drive Local Success

The new franchise in Charlotte will be spearheaded by the dynamic mother-daughter duo, Aweole and Ijeoma Nwaeze. With a solid background in healthcare and real estate, they aim to bring Daisy's proactive support program, DaisyCare, into the Southeast's burgeoning residential market. CEO Hagan Kappler emphasized Charlotte's growth potential, which will foster strong, long-term relationships with clients—critical for building a trusted local brand.

A Thriving Market and Experienced Leadership

Furthermore, existing franchise owner Chad Jasinski is expanding his successful operations into Las Vegas, leveraging his significant expertise in video wall systems. Known nationally as a leading expert, his expansion signifies Daisy's commitment to expert-driven service across its franchise network.

Texas Market Expansion with Fresh Leadership

In Texas, Eduardo Guerra, who successfully opened the Katy franchise, is launching another location in Sugar Land, further cementing Daisy’s presence in the Lone Star State. This franchise will be led by Perla Abel, an expert in luxury smart home technology. This new site illustrates Daisy's ability to identify and nurture local talent to resonate with a diverse clientele.

A New Era of Client-Centric Services

Central to Daisy’s strategic approach is its focus on recurring service revenues rather than solely relying on one-time installations. The DaisyCare program is pivotal in supporting franchisees and ensuring customer satisfaction through regular home visits—something that not only enhances customer loyalty but allows the company to maintain a remarkable Net Promoter Score of 84. Series of proactive support visits will likely exceed 10,000 this year, further solidifying its role in the smart home sector.

Tapping Into Entrepreneurial Spirit for Sustainable Growth

As Daisy continues its rapid expansion, it represents more than just growth; it embodies a model aimed at fostering partners' success. Its franchisees receive comprehensive operational support and business coaching, designed to build revenue predictability and deepen client relationships. The excitement entering this new year positions Daisy for a thriving 2026, appealing to both existing and prospective franchise operators looking to capitalize on the burgeoning demand for smart home services.

Tech Trends

0 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
05.12.2026

Defense Tech Helsing Nears $1.2B Funding Round, Valued at $18B

Update Helsing: A Major Player in Defense Technology Helsing, a European military drone startup, is making headlines by nearing a $1.2 billion funding round that is expected to elevate its valuation to approximately $18 billion. The Munich-based firm is not only attracting considerable investments from prominent firms like Dragoneer Investment Group and Lightspeed Venture Partners but is also considered one of the most valuable defense technology companies in Europe. Founded just five years ago, Helsing has rapidly ascended in the tech landscape, particularly in light of increased defense spending in Europe amidst the ongoing conflict in Ukraine. Unprecedented Growth and Strategic Importance In June 2025, Helsing successfully raised €600 million, around $14 billion at that time, indicating a significant increase in investor confidence and market potential. This new funding will be strategically vital for Helsing as it aims to expand its capabilities further into autonomous defense systems. The company is also currently under contract with the German military for €1.46 billion, which solidifies its position as a key supplier in the defense sector. The Landscape of Defense Technology Investments The surge in investment in autonomous defense startups like Helsing reflects a broader trend among venture capitalists who see significant growth opportunities in military technology, especially as geopolitical tensions rise. Competitors such as Quantum Systems and Tekever, though valuable in their own rights, have not yet reached the heights of Helsing’s latest valuation. This competitive atmosphere fuels innovation, with companies racing to develop advanced systems for air, land, and even underwater operations. Future Trends and Predictions As European defense strategies evolve, Helsing’s success may signal a pivotal shift in how technology is integrated into national security. With a focus on evolving capabilities, including their new submarine detection platform, Lura, Helsing is poised to play a critical role in strengthening Europe’s defense. Given the climate of escalating military needs, it’s likely that more tech firms will emerge, drawing attention from investors eager to seize the next big opportunity in defense technology. In conclusion, Helsing’s latest funding round not only marks a significant milestone for the company but also points to the increasing relevance and demand for innovative defense solutions in Europe. It will be interesting to track how these developments unfold and the implications for global security.

05.12.2026

Why Measuring Cholesterol with Apolipoprotein B can Transform Heart Health Insight

Update Understanding Cholesterol Testing: Beyond Just LDL For years, the medical community has centered cholesterol health around one crucial element: low-density lipoprotein (LDL) cholesterol. This 'bad cholesterol' is often monitored closely, with the simple mantra of lower LDL correlating to a lower risk of cardiovascular events like heart attacks and strokes. However, recent advancements in our understanding of cholesterol suggest that this singular focus might not tell the complete story. The Shift Toward Apolipoprotein B Testing Emerging research points toward a more comprehensive marker—apolipoprotein B (apoB)—which accounts not just for the cholesterol within LDL particles but also the actual number of LDL particles in the bloodstream. This distinction is crucial as two individuals could have identical LDL levels but vastly different risk profiles due to differing particle counts. Studies indicate that assessing apoB levels could better predict the risk of heart disease, making it a compelling alternative method. The Case for Change in Medical Guidelines In March 2026, the American Heart Association and American College of Cardiology took a notable step by recognizing apoB as a superior marker. Despite this, guidelines still primarily emphasize LDL testing. As Dr. Allan Sniderman of McGill University notes, while LDL is effective and well-understood, it limits the broader comprehension of cardiovascular risk. Why the Hesitation? The reluctance to switch testing methods may be influenced by decades of practice and the overwhelming success stories surrounding LDL tests and statins. "For 50 years, LDL cholesterol was an amazing discovery," Sniderman comments. Yet, this familiarity breeds inertia that could cost lives, as new evidence emerges that some patients—specifically those already on statins—still display high apoB levels and associated risks. A Broader Understanding of Heart Health Incorporating apoB testing into routine evaluations could ultimately lead to a more nuanced understanding of heart health. It’s not just about reducing what is perceived as 'bad' cholesterol; it’s about expanding our view of what governs cardiovascular health overall. The cholesterol conversation must evolve to include these newer metrics to ensure patients receive the most accurate assessments of their heart health and tailored treatment plans.

05.12.2026

Moving Beyond LDL Cholesterol: Why ApoB Testing Matters for Heart Risk

Update Redefining Cholesterol Risk: Why LDL Testing May Fall Short For decades, the narrative surrounding cholesterol risk has been dominant: lower your low-density lipoprotein (LDL), or "bad cholesterol," and reduce your chances of heart attacks and strokes. This well-known truism is largely built on LDL cholesterol testing, which measures the cholesterol inside LDL particles within the bloodstream. However, new insights reveal that relying solely on LDL levels can obscure a more nuanced understanding of cardiovascular health. The Case for Apolipoprotein B Testing Recent advancements in cholesterol testing have led experts to suggest exploring apolipoprotein B (apoB) as a more reliable indicator of heart health. Unlike standard LDL tests that measure cholesterol quantity, the apoB test provides a count of the actual lipid-carrying particles circulating in the blood. Two individuals may display identical LDL levels yet have vastly different particle numbers, leading to contrasting risk profiles for heart disease. Significantly, the AHA and ACC recognized apoB in their latest cholesterol guidelines, reinforcing its utility in accurately identifying patients at increased risk of heart complications. A study involving over a quarter-million adults demonstrated that utilizing apoB to guide treatment could reduce occurrences of heart attacks and strokes effectively, highlighting its advantages over traditional LDL-focused approaches. Understanding How ApoB Could Benefit You Understanding the nuances of apoB can be particularly beneficial for individuals with specific health conditions, such as diabetes or metabolic syndrome, where LDL may not capture heart disease risks accurately. Healthcare professionals are beginning to recommend apoB tests especially for patients who exhibit signs of unhealthy metabolism or possess family histories of heart issues. The disparity in how apolipoprotein B and LDL cholesterol measure risk parallels how two vehicles may travel the same highway at different speeds. Just as a bus full of passengers (high particle number) poses greater risk on the road than a single car (low particle number), individuals with higher apoB may face increased cardiovascular threats despite having normal LDL cholesterol levels. Actionable Steps for Better Heart Health So, what can individuals do with this information? Engaging with healthcare providers to discuss comprehensive cholesterol testing may be crucial. If your results reveal elevated apoB, consider adopting lifestyle changes like a balanced diet high in omega-3 fatty acids and regular exercise, as these have proven effective. Medical treatments targeting cholesterol, including statins and other lipid-lowering agents, could also be necessary for those with higher apoB values. Ultimately, understanding both LDL and apoB armed with knowledge empowers individuals to make informed decisions about their heart health, leading to better strategies for prevention and management of cardiovascular diseases.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*